The trademark application BIOLIFE CELLULAR THERAPY SERVICES was filed by Baxalta Incorporated, a U.S. corporation (the "Applicant"). The application was published for oppositions on April 11, 2022, and it was registered by office on July 19, 2022 without any oppositions.
The application was filed in English (German was selected as the second language).